IMS Company Profiles - Report Buyer

IMS COM PANY PRO FILES NOVARTIS SUBSIDIARY LISTING
OSPEN (pen i cil lin me dium/nar row spec trum)
BANEOCIN (an ti bi otic/sulphonamide top i cal)
THIOPENTAL (an es thetic gen eral)
Ther a peu tic Range:
antibacterials sys temic 73%
an ti bi ot ics, sulphonamides and antivirals top i cal
13%
an es thet ics 10%
dermatological antifungals 4%
Lead ing Dose Forms:
coated tab lets 49%
liq uids 15%
oint ments 13%
vi als 13%
cap sules 6%
CIBA VI SION
Street Ad dress: Bokserska 66, 02-690 Warsawa
Tel: +48 22 455 7585
Fax: +48 22 455 7580
Email: info.cvplwa@cibavision.novartis.com
Home Page: www.cibavision.pl
De scrip tion: Sales/detailer. Prod uct ranges in -
clude: oph thal mic prod ucts. Es tab lished 1998.
Sub sid iary of: Novartis, Po land (100%)
Phar ma ceu ti cal Sales: US$ 5-6 mil lion
Prod ucts (% of Sales by Lead ing 5):
95-100%
Ther a peu tic Classes (% of Sales by Lead ing
5): n.a.
Dose Forms (% of Sales by Lead ing 5): n.a.
Prin ci pal Prod ucts:
VITREOLENT (anticataract prep a ra tion)
MIOCHOL E (miotic/antiglaucoma prep a ra tion)
VITACIC (ophthalmological other)
Ther a peu tic Range:
ophthalmologicals 100%
Lead ing Dose Forms:
liq uids 100%
am poules -
HEXAL
Full Name: HEXAL POLSKA Sp. z.o.o.
Street Ad dress: Ul. Domaniewska 50C, 02-672
War saw
Tel: +48 22 549 1500
Fax: +48 22 549 1501
Email: hexal@hexal.com.pl
Home Page: www.hexal.com.pl
De scrip tion: Man u fac turer, im porter, dis trib u -
tor, pro moter, sales/detailer. Prod uct ranges in -
clude: phar ma ceu ti cal prod ucts (branded,
pre scrip tion, non-pre scrip tion), hos pi tal
pharmaceuticals, oph thal mic prod ucts.
Established 1993.
Con tacts (Pharm): Chair man: Andrzej
Trzeciakowski; Com mer cial Op er a tions: Er nest
Bartosik; Man u fac ture: Krzysztof Jagielski; Re -
search & De vel op ment: Dr Wojciech Nielubowicz;
Gen eral Con tact: Anna Zych
Phar ma ceu ti cal Sales: US$ 45-50 mil lion
Prod ucts (% of Sales by Lead ing 5): 60-65%
Ther a peu tic Classes (% of Sales by Lead ing
5): 75-80%
Dose Forms (% of Sales by Lead ing 5):
95-100%
Prin ci pal Prod ucts:
SIMVAHEXAL (cho les terol/triglyceride reg u lat ing
prep a ra tion)
PENTOHEXAL (ce re bral/pe riph eral
vasotherapeutic)
DICLAC (antirheumatic non-steroidal)
ACC (ex pec to rant)
LISIHEXAL (ACE in hib i tor plain)
Ther a peu tic Range:
cough and cold prep a ra tions 21%
lipid-reg u lat ing/antiatheroma prep a ra tions
18%
ce re bral/pe riph eral vasotherapeutics 16%
beta-block ing agents 13%
anti rheu ma tics sys temic 11%
Lead ing Dose Forms:
tab lets 66%
coated tab lets 24%
am poules 4%
pow ders/gran ules 3%
in fu sions 2%
LEK
Full Name: Lek Polska Sp.z.o.o.
Street Ad dress: ul. Podlipie 16, 95-010 Strykow
Tel: +48 42 710 6100
Fax: +48 42 710 6160
Home Page: www.lek.com.pl
De scrip tion: Man u fac turer, im porter, dis trib u -
tor, pro moter, sales/detailer. Im ports, dis trib utes,
pro motes, sells/de tails for other com pa nies. Prod -
uct ranges in clude: phar ma ceu ti cal prod ucts
(branded, pre scrip tion, non-pre scrip tion), hos pi -
tal pharmaceuticals, herbal prod ucts, vet er i nary
pharmaceuticals. Established 1991.
Con tacts (Pharm): Chair man: Marko Dolzan;
Com mer cial Op er a tions: Ryszard Morawski; Man -
u fac ture: Agnieszka Szworcer; Gen eral Con tact:
Ryszard Morawski
© 2009 IMS Health In cor po rated or its af fil i ates Page 196